Brief: Trinity Biotech Announces CE Mark Of Its Covid-19 IgG ELISA Antibody Test
05/01/2021 13:31
Jan 5 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES CE MARK OF ITS COVID-19 IGG
ELISA
ANTIBODY TEST
* TRINITY BIOTECH PLC - ACHIEVED CE MARK APPROVAL AND
REGISTRATION
FOR ITS COVID-19 IGG ELISA ANTIBODY TEST, CAPTIA SARS-COV-2 IGG
ELISA
Source text for Eikon: ID:nGNX8KqwLs
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM